BioInformant

Your Global Leader in Stem Cell Market Research

MENUMENU
  • Blog
    • Interviews
  • News
  • Stem Cells
    • iPS Cells
    • MSCs
    • HSCs
    • Adipose SCs
    • Neural Stem Cells
  • Exosomes
  • CAR-T
  • Cord Blood
  • Shop
    • Products
    • Submit PR
    • Advertise
  • About
    • Testimonials
    • Story
    • Guarantee
    • Contact
  • Home
  • Blog
    • Stem Cells
      • HSCs
      • iPS Cells
      • MSCs
      • Neural Stem Cells
      • Adipose SCs
    • Exosomes
    • Cell Therapy
      • CAR-T
    • Cord Blood
    • Stem Cell News
    • Interviews
  • COVID-19
  • Shop
  • Submit PR
  • Company
    • Advertise
    • Testimonials
    • Story
    • Job Posts
    • Guarantee
    • Privacy Policy
    • Contact
Home » AMAG Pharma

How Much Revenue Does Cord Blood Registry (CBR) Generate Per Year?

February 13, 2018 By Cade Hildreth (CEO) Leave a Comment

CRB Revenue from Cord Blood and Tissue Storage

Without a doubt, the three largest cord blood banks in the U.S. are:

  1. Cord Blood Registry (San Bruno, CA)
  2. Cryo-Cell (Oldsmar, FL)
  3. ViaCord (Waltham, MA)

These three companies are not only the three market leaders in the U.S. by number of cord blood and cord tissue units banked, but are also some of the largest cord blood banks worldwide. [Read more…]

Filed Under: Cord Blood Tagged With: AMAG Pharma, Cord Blood Registry

CBR® Acquisition by AMAG Pharma Further Bolsters Cord Blood Investment Environment

July 9, 2015 By Cade Hildreth (CEO) Leave a Comment

CRB® ACQUISITION BY AMAG PHARMA FURTHER BOLSTERS CORD BLOOD INVESTMENT ENVIRONMENT

The past few years have seen increasing investments made within the cord blood banking market, both by private equity and venture capital firms. These investments show the strength of the cord blood banking market. A summary of these investors is shown below.

Industry Investors within the Cord Blood Market

There have also been significant acquisitions made within the cord blood industry, with the largest cord blood bank within the United States, Cord Blood Registry, recently acquired by AMAG Pharmaceuticals in June of 2015 for $700 million. The purchase valued Cord Blood Registry at over 5.55 times revenue and over 15.55 times EBITDA.   [Read more…]

Filed Under: Cord Blood Tagged With: AMAG Pharma, CBR, cord blood, cord blood banking, cord blood investments, global cord blood banking market, industry investors

Nanocellect

Marathon Products

Let’s Get Social

  • Facebook
  • Twitter
  • LinkedIn
  • Pinterest
  • Instagram
Menu
  • Blog
  • Stem Cell News
    • Press Releases
  • Stem Cells
    • HSCs
    • iPS Cells
    • MSCs
    • Neural Stem Cells
    • Adipose SCs
  • Exosomes
  • Cell Therapy
    • CAR-T
  • Cord Blood
  • Interviews

Cart

Top Rated Products

  • Job Posting on BioInformant Job Posting on BioInformant.com - Your Perfect Hire Is In Our Audience
    Rated 0 out of 5
    $297
  • U.S. Cord Blood Banking Survey Cord Blood Banking Survey of U.S. Parents [2017]
    Rated 0 out of 5
    $197
  • Exosome Companies 2020 Global Database of Exosome Companies
    Rated 0 out of 5
    $149 $97
My Tweets

BioInformant's World-Class Clients

  • Submit Press Release
  • Advertise
  • Privacy and Terms

Copyright © 2022 · BIOINFORMANT, Your Global Leader in Stem Cell Market Research

| Email: Info@BioInformant.com | Phone: 703-859-7617 |

800 Corporate Drive, Suite 301, Stafford, VA 22554, United States

Disclaimer: All statements made on this website are NOT expressed as medical claims or advice. They are not intended to diagnose, treat, cure or prevent any disease or condition. If you have a health condition or concern, consult your physician or health care provider.